BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23461441)

  • 1. [Pharmaceutical care in renal insufficiency inpatients].
    Devesa García C; Matoses Chirivella C; Peral Ballester L; Sanz Tamargo G; Murcia López AC; Navarro Ruiz A
    Farm Hosp; 2012; 36(6):483-91. PubMed ID: 23461441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate drug dosage adjustments in patients with renal impairment.
    Markota NP; Markota I; Tomic M; Zelenika A
    J Nephrol; 2009; 22(4):497-501. PubMed ID: 19662605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine.
    Sweileh WM; Janem SA; Sawalha AF; Abu-Taha AS; Zyoud SH; Sabri IA; Al-Jabi SW; Jaradat NA; Zaid AA
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):908-12. PubMed ID: 17464934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia.
    Getachew H; Tadesse Y; Shibeshi W
    BMC Nephrol; 2015 Oct; 16():158. PubMed ID: 26446847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function.
    Spruill WJ; Wade WE; Cobb HH
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):153-60. PubMed ID: 18775390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of sotalol prescribing in a community hospital: opportunities for clinical pharmacist involvement.
    Finks SW; Rogers KC; Manguso AH
    Int J Pharm Pract; 2011 Aug; 19(4):281-6. PubMed ID: 21733016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of medication-related problems among patients with renal compromise in an Indian hospital.
    Castelino RL; Sathvik BS; Parthasarathi G; Gurudev KC; Shetty MS; Narahari MG
    J Clin Pharm Ther; 2011 Aug; 36(4):481-7. PubMed ID: 21535060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage adjustment in medical patients with renal impairment at Groote Schuur Hospital.
    Decloedt E; Leisegang R; Blockman M; Cohen K
    S Afr Med J; 2010 May; 100(5):304-6. PubMed ID: 20460024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment.
    Park EJ; Wu K; Mi Z; Dong T; Lawrence JP; Ko CW; Huang SM; Zhang L; Crentsil V; Zhang J; Xu NN
    Ann Pharmacother; 2012 Sep; 46(9):1174-87. PubMed ID: 22932303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A set of simple aids to drug dosage adjustment in renal insufficiency.
    Janků I; Modr Z; Krebs V
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):27-32. PubMed ID: 2303310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of renal risk drugs in hospitalized patients with impaired renal function--an underestimated problem?
    Blix HS; Viktil KK; Moger TA; Reikvam A
    Nephrol Dial Transplant; 2006 Nov; 21(11):3164-71. PubMed ID: 16880181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal insufficiency increases mortality in acute coronary syndromes regardless of TIMI risk score.
    Dudek D; Chyrchel B; Siudak Z; Depukat R; Chyrchel M; Dziewierz A; Mielecki W; Rakowski T; Rzeszutko Ł; Dubiel J
    Kardiol Pol; 2008 Jan; 66(1):28-34; discussion 35-6. PubMed ID: 18266185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical interventions in prescriptions for patients admitted with chronic renal failure.
    Arrabal-Durán P; Durán-García ME; Ribed-Sánchez A; Hidalgo-Collazos P; Sanjurjo-Sáez M
    Nefrologia; 2014 Nov; 34(6):710-5. PubMed ID: 25415570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of a pharmaceutical interventional programme in patients on medications with renal risk].
    Alvarez Arroyo L; Climent Grana E; Bosacoma Ros N; Roca Meroño S; Perdiguero Gil M; Ordovás Baines JP; Sánchez Payá J
    Farm Hosp; 2009; 33(3):147-54. PubMed ID: 19712598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study.
    Pai AB; Boyd A; Depczynski J; Chavez IM; Khan N; Manley H
    Pharmacotherapy; 2009 Dec; 29(12):1433-40. PubMed ID: 19947803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug dosage adjustments according to renal function at hospital discharge.
    van Dijk EA; Drabbe NR; Kruijtbosch M; De Smet PA
    Ann Pharmacother; 2006; 40(7-8):1254-60. PubMed ID: 16804098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safe drug prescribing for patients with renal failure].
    Tanaka A; Shimizu H; Matsuo S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():58-66. PubMed ID: 18074518
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of varying degrees of renal dysfunction on transcatheter and surgical aortic valve replacement.
    Nguyen TC; Babaliaros VC; Razavi SA; Kilgo PD; Guyton RA; Devireddy CM; Shults CC; Mavromatis K; Kanitkar M; Block P; Lerakis S; Thourani VH
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1399-406; discussion 13406-7. PubMed ID: 24075566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strength of evidence for labeled dosing recommendations in renal impairment.
    Gagne JJ; Khan NF; Raj TS; Patel LR; Choudhry NK
    Clin Trials; 2017 Apr; 14(2):219-221. PubMed ID: 27780884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.